This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Revia

Teva Pharmaceutical Industries Ltd.

Drug Names(s): naltrexone hydrochloride

Description: REVIA is a pure opioid antagonist that blocks the effects of opioids by competitive binding at opioid receptors. The mechanism of action of REVIA in alcoholism is not understood; however, involvement of the endogenous opioid system is suggested by preclinical data.

Deal Structure: In December 2008, Teva closed its acquisition of Barr.


Revia News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug